Improved Vaccine Efficacy via Dendridic Cells and Flavivirus Vectors
Dr. Steinman’s team is developing vaccines that stimulate the immune system’s dendritic cells, which are known to play an important role in stimulating protection against infectious diseases. One approach is to engineer vaccine antigens into monoclonal antibodies against receptors on the surface of dendritic cells. A secondary approach involves engineering genes for the antigens of interest into the yellow fever virus. The project will focus on creating experimental vaccines for a range of diseases, including HIV and malaria. If successful, this technology could identify a better way to create vaccines that stimulate multiple components of the body’s immune response, including those that have been difficult to target with existing vaccine approaches.